WHO vaccine-preventable diseases: monitoring system. 2015 global summary

Last updated 15-Jul-2015 (Data received as of 10-Jul-2015)
Next overall update Fall 2015
EPI mother and child logo         
Select a country

Development status: Economy in transition GNI / capita (US$): 1'2501 Infant (under 12 months) mortality rate: 242
GDP / capita (US$): 3'3221 Child (under 5 years) mortality rate: 272

Population data in thousands3

  2014  2013  2012  2011  2010  2000  1990  1980 
Total population 5'625  5'548  5'474  5'403  5'334  4'955  4'395  3'627 
Births 152  151  148  144  140  108  136  108 
Surviving infants 147  146  143  140  135  103  127  99 
Pop. less than 5 years 697  681  659  631  595  546  629  488 
Pop. less than 15 years 1'722  1'684  1'652  1'625  1'603  1'733  1'651  1'347 
Female 15-49 years 1'525  1'523  1'520  1'515  1'506  1'297  1'032  857 

Number of reported case

(Click for retrospective incidence data for Kyrgyzstan)
Diphtheria 15 
Japanese encephalitis
Measles 318  222  16  584 
Mumps 694  350  300  396  350 
Pertussis 90  62  77  109  34  237 
Polio*
Rubella 24  12  176 
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)**
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Kyrgyzstan)
Vaccine year result method % card seen                                                
BCG 2011  99  DHS   86  97  98  98  98  98  96 
DTP1 2011  98  DHS   86  96  99  97  97  99  99 
DTP3 2011  85  DHS   86  96  97  96  96  96  99 
DTP4          95 
IPV1         
HepB_BD          99  96  94  73  99  45 
HepB3 2011  85  DHS   86  96  97  96  96  96  44 
Hib3 2011  85  DHS   86  96  97  96  96  96 
JapEnc         
MCV1          96  99  98  97  99  98 
MCV2          97  97  98  98  98  96 
PCV1         
PCV3         
Pol3 2011  79  DHS   86  95  97  94  94  88  99 
Rota1         
Rota_last         
Rubella1          96  99  97 
TT2plus         
PAB         
VAD1          98 
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: Mid July 2016

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Kyrgyzstan)
BCG 97  98  98  98  98  96 
DTP1 96  98  96  97  99  99 
DTP3 96  97  96  96  96  99 
HepB3 96  97  96  96  96  44 
HepB_BD 99  96  94  73  99  45 
Hib3 96  97  96  96  96 
MCV1 96  99  98  97  99  98 
MCV2 97  97  98  98  98  96 
PCV3
Pol3 95  97  94  94  88  99 
Rota_last

Number of districts in the country 40  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 100
From 80 to 89% 0
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2014 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DT 6 years; Yes
DTwP 2 years; Yes
DTwPHibHepB 2, 3.5, 5 months; Yes
HepB_Pediatric birth; Yes
MMR 12 months; 6 years; Yes
OPV birth; 2, 3.5, 5 months; Yes
Td 11, 16, 26, 36, 46, 56 years; Yes

Immunizaton indicators

Indicator Expected answer 2014  2013  2012  2011  2010  2009  2008 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2012-2016  2013-2017  2006-2012  2011-2016  2006-2010  2006-2010  2006-2010 
Nº of districts with microplans that include activities to raise immunization coverage number 40  40    40  Yes  47  45 

System performance

Total Nº districts in country number 40  40  40  40  42  52  52 
Nº districts with DTP3 coverage >=80% number 40  40  40  40 
% of districts with DTP3 coverage >=80% From 0 to 100% 100  100  100  100 
Nº districts with measles (MCV1) coverage >=95% number   40  40  38  42     
% of districts with MCV1 coverage >=95% From 0 to 100% 100  100  95  100     

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes  Yes     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 13      64   

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  No  Yes     

Sources

 1  "The 2015 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.